- Home
- AVNS vs CSTL Comparison
AVNS vs CSTL Comparison
Compare AVNS & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVNS
- CSTL
- Stock Information
- Founded
- AVNS 2014
- CSTL 2007
- Country
- AVNS United States
- CSTL United States
- Employees
- AVNS N/A
- CSTL N/A
- Industry
- AVNS Industrial Specialties
- CSTL Medical Specialities
- Sector
- AVNS Health Care
- CSTL Health Care
- Exchange
- AVNS Nasdaq
- CSTL Nasdaq
- Market Cap
- AVNS 717.8M
- CSTL 576.3M
- IPO Year
- AVNS N/A
- CSTL 2019
- Fundamental
- Price
- AVNS $15.23
- CSTL $20.21
- Analyst Decision
- AVNS Hold
- CSTL Strong Buy
- Analyst Count
- AVNS 1
- CSTL 6
- Target Price
- AVNS N/A
- CSTL $40.00
- AVG Volume (30 Days)
- AVNS 450.8K
- CSTL 453.1K
- Earning Date
- AVNS 05-01-2025
- CSTL 05-01-2025
- Dividend Yield
- AVNS N/A
- CSTL N/A
- EPS Growth
- AVNS N/A
- CSTL N/A
- EPS
- AVNS N/A
- CSTL 0.62
- Revenue
- AVNS $687,800,000.00
- CSTL $332,069,000.00
- Revenue This Year
- AVNS $2.70
- CSTL N/A
- Revenue Next Year
- AVNS $0.69
- CSTL $6.01
- P/E Ratio
- AVNS N/A
- CSTL $32.60
- Revenue Growth
- AVNS 2.15
- CSTL 51.09
- 52 Week Low
- AVNS $14.40
- CSTL $16.97
- 52 Week High
- AVNS $25.36
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- AVNS 38.79
- CSTL 25.47
- Support Level
- AVNS $14.89
- CSTL $20.34
- Resistance Level
- AVNS $15.44
- CSTL $22.58
- Average True Range (ATR)
- AVNS 0.67
- CSTL 1.56
- MACD
- AVNS -0.03
- CSTL -0.57
- Stochastic Oscillator
- AVNS 35.32
- CSTL 7.89
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME, among others. The company's test portfolio consists of test offerings to aid clinicians in the diagnosis and treatment of cancers or precancerous diagnoses in the fields of dermatology, gastroenterology, and ophthalmology and a pharmacogenomics ("PGx") test to guide optimal drug treatment for patients diagnosed with depression, anxiety, and other mental health conditions.